
|Articles|September 1, 2003
- Volume 0 0
Learning Objectives
Advertisement
Learning Objectives
After reading these articles, the reader should be able to:
- Describe current and emerging pharmacologic options for lipid lowering therapy
- Explain how to intensify lipid-lowering therapy if necessary to achieve National Cholesterol Education Program goals
- Provide suggestions for effective patient counseling about lipid-lowering therapy and goals.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Survodutide Cuts Visceral Fat and Normalizes Liver Fat in MASLD. Here's What the Data Mean for Metabolic Risk
2
The Hidden Reimbursement Crisis in Medicare’s Drug Price Negotiation Program
3
ADA 2026: Optimized Inhaled Insulin Dosing Outperforms Subcutaneous Analogs for Postprandial Glucose in T1D
4
FDA Grants Breakthrough Therapy Designation to Investigational Cannabis-Derived Therapy for Chronic Low Back Pain
5






































































































































